CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 7 enrolled
Drug / intervention
Trimethoprim +2 moredrug
Likely dose
Trimethoprim 300mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03746106
NCT03746106Phase 4Completed

The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine

University of California, San Francisco·interventional·Posted Nov 19, 2018·Updated Jan 3, 2025

In Brief

A Phase 4 clinical trial evaluating Trimethoprim, Metformin, and 1 other intervention for Vitamin B1 Deficiency and Thiamine Deficiency. Completed, enrolled 7 participants across 1 site.

Detailed Summary

In Part 1, subjects will be administered thiamine, thiamine with metformin, and thiamine with trimethoprim. Part 2 will expand on Part 1 and subjects will be administered thiamine and thiamine with trimethoprim. The goal is to determine whether taking a drug and a vitamin together affects the body's ability to absorb, distribute, and eliminate thiamine (Vitamin B1).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedNov 19, 2018
Enrollment StartJan 28, 2019
Primary CompletionAug 10, 2023
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 7.6 years ago

Interventions

Trimethoprimdrug

300mg of trimethoprim will be given in combination with 5mg thiamine and compared to 5mg thiamine only for both Parts 1 and 2 of the study.

Metformindrug

1000mg of metformin will be given in combination with 5mg thiamine and compared to 5mg thiamine only in Part 1 of the study.

Vitamin B1dietary

5mg of thiamine will be given alone and in combination for both Parts 1 and 2 of the study.